Liquidia Corporation - Common Stock – Bilanz (NASDAQ:LQDA) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 99.53 M93.73 M129.2 M118.33 M230.31 M327.93 M Gesamtverbindlichkeiten 28.45 M28.46 M38.78 M71.04 M153.04 M283.19 M Gesamtkapital 71.09 M65.27 M90.42 M47.29 M77.28 M44.75 M Gesamtverbindlichkeiten und Eigenkapital 99.53 M93.73 M129.2 M118.33 M230.31 M327.93 M Gesamtverschuldung 10.29 M10.41 M19.88 M19.88 M—— Nettoverschuldung 10.29 M10.41 M19.88 M19.88 M——

Nachrichten

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

Aktie von Liquidia Technologies erreicht Allzeithoch bei 62,31 USD

Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy

Liquidia: CEO verkauft Aktien im Wert von 4,58 Mio. US-Dollar

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

AGIO's Pyrukynd Gets Approval for Thalassemia in Europe

GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy

CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity